Avgerinos A, Armonis A, Manolakopoulos S, Poulianos G, Rekoumis G, Sgourou A, Gouma P, Raptis S
2nd Department of Gastroenterology, Evangelismas Hospital, Athens, Greece.
J Hepatol. 1997 May;26(5):1034-41. doi: 10.1016/s0168-8278(97)80112-2.
BACKGROUND/AIMS: Long-term endoscopic injection sclerotherapy of oesophageal varices prevents rebleeding in patients with cirrhosis surviving an acute variceal bleeding episode. However, this treatment is associated with a substantial complication rate. Endoscopic band ligation is a newly developed technique in an attempt to provide a safer alternative. The aim of this study was to compare the efficacy and safety of injection sclerotherapy versus variceal ligation in the management of patients with cirrhosis after variceal haemorrhage.
Seventy-seven patients with cirrhosis who proved to have oesophageal variceal bleeding were studied. After initial control of haemorrhage by sclerotherapy, 40 of the patients were randomly assigned to sclerotherapy and 37 to ligation. Both procedures were performed under midazolam sedation at intervals of 7-14 days until all varices in the distal oesophagus were eradicated or were too small to receive further treatment.
The eradication of varices required a lower mean number of sessions with ligation (3.7 +/- 1.9) than with sclerotherapy (5.8 +/- 2.7, p = 0.002). The mean duration of follow-up was similar in both groups (15.6 months +/- 7.3 and 15 +/- 7.4, respectively). The proportion of patients remaining free from recurrent bleeding against time was significantly higher in the ligation group as compared to the sclerotherapy group (chi 2 = 3.86, p = 0.05). Only 13 patients (35%) developed complications in the ligation group as compared to 24 (60%, p = 0.05) in the sclerotherapy group. The mortality rate was similar in both groups (20% and 21%, respectively).
Variceal ligation is better than sclerotherapy in the long-term management of patients with cirrhosis after variceal haemorrhage which was initially controlled with sclerotherapy.
背景/目的:长期内镜下食管静脉曲张硬化治疗可预防肝硬化患者急性静脉曲张出血发作后再出血。然而,这种治疗方法的并发症发生率较高。内镜下套扎术是一种新开发的技术,旨在提供一种更安全的替代方法。本研究的目的是比较硬化治疗与静脉曲张套扎术在静脉曲张出血后肝硬化患者管理中的疗效和安全性。
对77例经证实有食管静脉曲张出血的肝硬化患者进行研究。在通过硬化治疗初步控制出血后,40例患者被随机分配接受硬化治疗,37例接受套扎术。两种手术均在咪达唑仑镇静下进行,间隔7 - 14天,直到食管远端所有静脉曲张被根除或太小无法接受进一步治疗。
与硬化治疗(5.8±2.7次,p = 0.002)相比,套扎术消除静脉曲张所需的平均疗程数更低(3.7±1.9次)。两组的平均随访时间相似(分别为15.6个月±7.3个月和15±7.4个月)。与硬化治疗组相比,套扎术组无复发出血患者随时间的比例显著更高(χ² = 3.86,p = 0.05)。套扎术组仅有13例患者(35%)出现并发症,而硬化治疗组为24例(60%,p = 0.05)。两组的死亡率相似(分别为20%和21%)。
在最初通过硬化治疗控制出血的静脉曲张出血后肝硬化患者的长期管理中,静脉曲张套扎术优于硬化治疗。